PRODUCT INFORMATION
Description
CSTSMLKAC (Cys-Ser-Thr-Ser-Met-Leu-Lys-Ala-Cys) is a cyclic nine-amino-acid peptide (Cys1-Cys9 disulfide bridge) that mimics an endogenous sequence. It has been reported to specifically home to cardiomyocytes within the ischemic myocardium in animal models. This makes it a candidate for in vitro and in vivo research into cardiac-targeted molecular delivery strategies.
Molecular Weight
941.15
Purity
> 95%
Formula
C₃₆H₆₄N₁₀O₁₃S₃
Product Type
Targeting Peptide
Sequence
Cys-Ser-Thr-Ser-Met-Leu-Lys-Ala-Cys (Disulfide bridge: Cys1-Cys9)
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- Cys-PKHB1 Targeting Peptide (CAT#: OLY-1025-YS-33)
- H-Gly-Arg-Gly-Asp-Ser-NH2 Targeting Peptide (CAT#: OLY-1025-YS-15)
- FFAGLDD Targeting Peptide (CAT#: OLY-1025-YS-43)
- Bonemarrow-Derived Mesenchymal Stem Cells Affinity Peptide (CAT#: OLY-1025-YS-44)
- IETP2 Targeting Peptide (CAT#: OLY-1025-YS-30)
- CXCL9(74-103) Targeting Peptide (CAT#: OLY-1025-YS-42)
- WLSEAGPVVTVRALRGTGSW TFA Targeting Peptide (CAT#: OLY-1025-YS-67)
- Cyclo(RGDfK(Mal)) Targeting Peptide (CAT#: OLY-1025-YS-46)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.